pubrio
Sobi - Swedish Orphan Biovitrum AB (publ)

Sobi - Swedish Orphan Biovitrum AB (publ)

Sweden · Pharmaceuticals

Pharmaceuticals

Biotechnology

Healthcare

Sobi is a specialised international biopharmaceutical company transforming the lives of people with rare diseases. We provide sustainable access to innovative therapies in the areas of haematology, immunology and specialty indications. Today, we employ approximately 1,800 people across Europe, North America, the Middle East and Asia. In 2022, our revenue amounted to SEK 18.8 billion. The Sobi share (STO:SOBI) is listed on Nasdaq Stockholm. You can find more information about Sobi at sobi.com.

Company Insights
Company Overview

2009

Founded

Pharmaceuticals

Industry

Sweden

Location

1,448,467

Ranking

2,200 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Sobi - Swedish Orphan Biovitrum AB (publ)

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​